Form 4: Stryker Director Rajeev Suri Receives RSU Grant
Statement of Changes in Beneficial Ownership
Stryker Corporation director Rajeev Suri was granted 762 restricted stock units as part of his compensation package.
Summary
- Director Rajeev Suri acquired 762 restricted stock units (RSUs) on May 6, 2026.
- Each RSU represents a contingent right to receive one share of Stryker common stock.
- The RSUs are scheduled to vest on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027.
- Following this transaction, the director's total beneficial ownership of common stock is 7,190 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- Market volatility affecting the future value of the granted equity.
Future Outlook
The RSUs will vest in May 2027, subject to the director's continued service.
Industry Context
StockSavvy.ai notes that this is a routine equity compensation disclosure for a board member, consistent with standard corporate governance practices in the medical technology sector.
Comparison to Industry Standards
- The grant of RSUs to non-employee directors is a standard practice among S&P 500 companies to ensure alignment with shareholder interests.
- The vesting schedule of approximately one year is consistent with typical annual director compensation cycles.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Updated Power of Attorney authorizing specific individuals to file SEC documents on behalf of the director. | 2025-08-20 | Administrative update to ensure compliance with SEC filing requirements. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation grant.
Next Steps
- Vesting of the 762 RSUs on or before May 6, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-08-20 | Execution date of the Power of Attorney for SEC filings. |
| 2026-05-06 | Transaction date of the RSU grant. |
| 2027-05-06 | Expected vesting date of the RSU grant. |
Keywords
Stryker, SYK, Director Compensation, Restricted Stock Units, Insider Transaction, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.